Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2007-08-02
Original market date: See footnote 1
1978-12-31
Product name:
TRAVASOL INJ WITHOUT ELECTROLYTES 5.5%
DIN:
00388742 Electronic product monograph is not available
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
14
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA01 AMINO ACIDS
Active ingredient group (AIG) number:See footnote5
1414586005
Active ingredient(s) | Strength |
---|---|
ARGININE | 570 MG / 100 ML |
GLYCINE | 1.14 G / 100 ML |
HISTIDINE | 241 MG / 100 ML |
ISOLEUCINE | 263 MG / 100 ML |
L-ALANINE | 1.14 G / 100 ML |
L-LYSINE HYDROCHLORIDE | 318 MG / 100 ML |
LEUCINE | 340 MG / 100 ML |
METHIONINE | 318 MG / 100 ML |
PHENYLALANINE | 340 MG / 100 ML |
PROLINE | 230 MG / 100 ML |
THREONINE | 230 MG / 100 ML |
TRYPTOPHAN | 99 MG / 100 ML |
TYROSINE | 22 MG / 100 ML |
VALINE | 252 MG / 100 ML |